期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 66, 期 11, 页码 7645-7656出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.3c00555
关键词
-
Ubiquitin phosphorylation by PINK1 is crucial for mitophagy and potential PD treatments. N (6)-substituted adenosines, like kinetin riboside and N (6)-benzyladenosine, activate PINK1 and induce mitophagy in cells. Moreover, these adenosines can inhibit elevated ubiquitin phosphorylation induced by mitochondrial depolarizing agents.
Ubiquitin phosphorylation by the mitochondrial proteinkinase PTEN-inducedkinase 1 (PINK1), upon mitochondrial depolarization, is an importantintermediate step in the recycling of damaged mitochondria via mitophagy.As mutations in PINK1 can cause early-onset Parkinson's disease(PD), there has been a growing interest in small-molecule activatorsof PINK1-mediated mitophagy as potential PD treatments. Herein, weshow that N (6)-substituted adenosines, suchas N (6)-(2-furanylmethyl)-adenosine (knownas kinetin riboside) and N (6)-benzyladenosine,activate PINK1 in HeLa cells and induce PINK1-dependent mitophagyin primary mouse fibroblasts. Interestingly, pre-treatment of HeLacells and astrocytes with these compounds inhibited elevated ubiquitinphosphorylation that is induced by established mitochondrial depolarizingagents, carbonyl cyanide m-chlorophenyl-hydrazineand niclosamide. Together, this highlights N (6)-substituted adenosines as progenitor PINK1 activators thatcould potentially be developed, in the future, as treatments for agedand sporadic PD patients who have elevated phosphorylated ubiquitinlevels in the brain.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据